Cyclobenzaprine is NOT a Benzodiazepine or an NSAID
Your provider is incorrect—cyclobenzaprine is neither a benzodiazepine nor an NSAID. It is a centrally acting skeletal muscle relaxant that is structurally related to tricyclic antidepressants, specifically amitriptyline. 1, 2
What Cyclobenzaprine Actually Is
Cyclobenzaprine is a tricyclic amine compound that functions as a skeletal muscle relaxant through central nervous system mechanisms 1, 2. The drug:
- Acts as a 5-HT2 receptor antagonist in the central nervous system 1
- Is structurally identical to the tricyclic antidepressant amitriptyline 3, 1, 2
- Works centrally, not directly on skeletal muscle 1
- Has peripheral and central anticholinergic activity 1
Why the Confusion Exists
The confusion likely stems from three sources:
Benzodiazepine confusion: Both benzodiazepines (like diazepam) and cyclobenzaprine are used for muscle spasm, but they are completely different drug classes 4, 5. Benzodiazepines are GABA-A agonists 6, while cyclobenzaprine is a tricyclic compound with serotonergic and anticholinergic effects 1.
NSAID confusion: Cyclobenzaprine is often prescribed alongside NSAIDs for musculoskeletal pain 7, 2, but it has no anti-inflammatory properties whatsoever. NSAIDs work by inhibiting COX-1 and COX-2 enzymes 7, while cyclobenzaprine modulates central neurotransmitter systems.
Side effect overlap: Cyclobenzaprine causes sedation and drowsiness 1, 2, similar to benzodiazepines, but through different mechanisms—likely via off-target antagonism of central histamine H1 receptors 8 and anticholinergic effects 1.
Clinical Implications of This Misclassification
This distinction matters for patient safety:
- Cyclobenzaprine carries risks similar to tricyclic antidepressants, including potential for arrhythmias, sinus tachycardia, and prolonged cardiac conduction 2
- Serotonin syndrome risk exists when combined with SSRIs, SNRIs, MAO inhibitors, or tramadol 1, 2—a risk not present with benzodiazepines
- Anticholinergic effects (dry mouth, urinary retention, confusion, constipation) are prominent 1, 2—different from benzodiazepine side effects
- Not a controlled substance like benzodiazepines, though withdrawal symptoms (malaise, nausea, headache) can occur with long-term use 1
The Evidence on Efficacy
Cyclobenzaprine is classified as a skeletal muscle relaxant in clinical guidelines 7, with evidence showing:
- Benefit for acute musculoskeletal pain (short-term use of 2-4 weeks) 1, 4
- Some benefit for fibromyalgia 7
- No direct muscle relaxation effect—the term "muscle relaxant" is misleading as it works centrally, not on muscle tissue 6, 3
- Recent evidence suggests no superiority over placebo when combined with NSAIDs for acute low back pain 9
Bottom line: Educate your provider that cyclobenzaprine is a tricyclic compound structurally related to amitriptyline, not a benzodiazepine or NSAID, and this distinction has important implications for drug interactions, side effects, and patient counseling.